HFA decreased expression of osteoclastic markers in alveolar bone. by Mani Alikhani (5180768)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

“…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant. by Esther Magdalena Marquez-Lona (4183126)

“…<p>(A) Lysates from strains in stationary phase (A₆₀₀>5.0) were subjected to native gel electrophoresis followed by an in-gel activity assay with the fluorogenic proteasome substrate Suc-LLVY-AMC. …”

Cerebral deep gray matter volume change over 5 years with the FreeSurfer pipeline. by Renxin Chu (5169857)

Subjects:

Cerebral deep gray matter volume change over 5 years with the FSL-FIRST pipeline. by Renxin Chu (5169857)

Subjects:

Changes in the melting points of each formulation of 0.1% FLU ophthalmic suspensions. by Tokio Obata (10783047)

Subjects:

LiCl administered via 0.5% LiCl food pellets for 4 wks decreases the antioxidant stress response. by Christine M. LaPash Daniels (796881)

“…<p>(A) LiCl decreases <i>Nrf2</i> transcripts in hippocampus and cortex of R236H/+ mice (N = 5 male mice per group). …”

Fold decrease in virulence gene expression of <i>Salmonella in vivo</i> and <i>in vitro</i>^a. by Xiaojian Yang (295141)

“…Values represent down-regulation (fold-decrease) of gene expression.</p>#<p>Value for each gene represents a significant difference (<i>P</i><0.05) between the treatment and control samples in the <i>in vitro</i> experiment. …”

 Performance of NLLSS under the validation framework of LOOCV, 10-fold CV, 5-fold CV, and 3-fold CV, which have demonstrated the NLLSS has a reliable and robust performance. by Xing Chen (140292)

A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”

Homozygous deletion of <i>ERG251</i> leads to the decreased ergosterol accumulation in the absence of FLC and decreased production of toxic dienol in the presence of FLC. by Xin Zhou (54275)

Rank importance, where impairment at a point has a significant association with decreased vision-related quality of life. by Hiroshi Murata (387321)

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4 by Jin Zhou (90734)

Efficacy end points. by Youngmin Ko (3333819)

Subjects:

Plasma from ATTR individuals presents a higher proteolytic activity. by Gonçalo da Costa (198731)

Five-hours-old clots were subjected to scanning electron microscopy. by Jan Víteček (11434774)

Demyelination/remyelination and decreased P0 expression in dKO mice. by Valérie Brügger (800377)